# FORT (NCT04984343)

> Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04984343
- Phase: PHASE2
- Status: TERMINATED
- Sponsor: Weill Medical College of Cornell University
- Conditions: Prostate Cancer
- Interventions: Radiation Therapy
- Enrollment: 33
- Primary outcome: Change in the number of patient-reported GI symptoms using the Expanded Prostate Cancer Index Composite (EPIC)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 15
- Bluesky threads: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=fort-nct04984343

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04984343", "email": "<work email>"}; the inbox owner confirms by the emailed link.